Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04721912 · ClinicalTrials.gov registry record · Phase 3
Group B Streptococcus Response After Probiotic Exposure
A Phase 3 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 3
- Development phase
- 68
- Enrollment target
NCT04721912 is a Phase 3 study that has completed, run by University of New Mexico. The registered enrollment target is 68 participants.
The verdict
NCT04721912, a Phase 3 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 68 participants
- Enrollment target
Study Summary
This is an open-label randomized control trial and feasibility study designed to determine the feasibility of a larger RCT in our setting that would examine prenatal probiotic use in Group B Strep (GBS) positive pregnant women at term. Investigators hope to address the question of whether prenatal oral probiotic use, taken by healthy low risk GBS positive women from approximately 37 weeks gestation until the time of birth, will reduce the number of women who test positive for GBS at the time of admission to Labor and Delivery (L\&D).
Interventions
- DRUG Probiotic dietary supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2020-12-24 |
| Est. Completion | 2023-08-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04721912
The ClinicalTrials.gov registry entry for NCT04721912 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Probiotic dietary supplement is the first listed.
NCT04721912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04721912 about?
NCT04721912 is a clinical study titled "Group B Streptococcus Response After Probiotic Exposure". This is an open-label randomized control trial and feasibility study designed to determine the feasibility of a larger RCT in our setting that would examine prenatal probiotic use in Group B Strep (GBS) positive pregnant women at term. Investigators hope to address the question of whether prenatal o...
What is the current status of trial NCT04721912?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 68 participants. The study started on 2020-12-24. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04721912?
The interventions under investigation include: Probiotic dietary supplement (DRUG).
Who is sponsoring clinical trial NCT04721912?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.